Supplementary Figure 5 from BCR-ABL–Induced Deregulation of the IL-33/ST2 Pathway in CD34(+) Progenitors from Chronic Myeloid Leukemia Patients Article Swipe

View

Anaïs Levescot , Stéphane Flamant , Sara Basbous , Florence Jacomet , Olivier Féraud , Elvire Anne Bourgeois , Marie‐Laure Bonnet , Christine Giraud , Lydia Roy , Anne Barra , Jean‐Claude Chomel , Ali G. Turhan , François Guilhot , Jean‐Philippe Girard , Jean‐Marc Gombert , André Herbelin ·

YOU? · · 2023 · Open Access · · DOI: https://doi.org/10.1158/0008-5472.22398365.v1

PDF file - 154KB, CML-CP CD34(+) cells proliferate in response to IL-33 independently from GM-CSF.

Related Topics

Acute Myeloid Leukemia

Concepts

Myeloid leukemia Progenitor cell Cancer research Medicine Deregulation CD34 Haematopoiesis Immunology Biology Cell biology Stem cell Economics Macroeconomics

Metadata

Type: preprint
Language: en
Landing Page: https://doi.org/10.1158/0008-5472.22398365.v1
OA Status: gold
Related Works: 10
OpenAlex ID: https://openalex.org/W4361239791

All OpenAlex metadata

Raw OpenAlex JSON

OpenAlex ID: https://openalex.org/W4361239791

Canonical identifier for this work in OpenAlex
DOI: https://doi.org/10.1158/0008-5472.22398365.v1

Digital Object Identifier
Title: Supplementary Figure 5 from BCR-ABL–Induced Deregulation of the IL-33/ST2 Pathway in CD34(+) Progenitors from Chronic Myeloid Leukemia Patients

Work title
Type: preprint

OpenAlex work type
Language: en

Primary language
Publication year: 2023

Year of publication
Publication date: 2023-03-30

Full publication date if available
Authors: Anaïs Levescot, Stéphane Flamant, Sara Basbous, Florence Jacomet, Olivier Féraud, Elvire Anne Bourgeois, Marie‐Laure Bonnet, Christine Giraud, Lydia Roy, Anne Barra, Jean‐Claude Chomel, Ali G. Turhan, François Guilhot, Jean‐Philippe Girard, Jean‐Marc Gombert, André Herbelin

List of authors in order
Landing page: https://doi.org/10.1158/0008-5472.22398365.v1

Publisher landing page
Open access: Yes

Whether a free full text is available
OA status: gold

Open access status per OpenAlex
OA URL: https://doi.org/10.1158/0008-5472.22398365.v1

Direct OA link when available
Concepts: Myeloid leukemia, Progenitor cell, Cancer research, Medicine, Deregulation, CD34, Haematopoiesis, Immunology, Biology, Cell biology, Stem cell, Economics, Macroeconomics

Top concepts (fields/topics) attached by OpenAlex
Cited by: 0

Total citation count in OpenAlex
Related works (count): 10

Other works algorithmically related by OpenAlex

Full payload

id	https://openalex.org/W4361239791
doi	https://doi.org/10.1158/0008-5472.22398365.v1
ids.doi	https://doi.org/10.1158/0008-5472.22398365.v1
ids.openalex	https://openalex.org/W4361239791
fwci	0.0
type	preprint
title	Supplementary Figure 5 from BCR-ABL–Induced Deregulation of the IL-33/ST2 Pathway in CD34(+) Progenitors from Chronic Myeloid Leukemia Patients
biblio.issue
biblio.volume
biblio.last_page
biblio.first_page
topics[0].id	https://openalex.org/T11215
topics[0].field.id	https://openalex.org/fields/27
topics[0].field.display_name	Medicine
topics[0].score	0.9972000122070312
topics[0].domain.id	https://openalex.org/domains/4
topics[0].domain.display_name	Health Sciences
topics[0].subfield.id	https://openalex.org/subfields/2720
topics[0].subfield.display_name	Hematology
topics[0].display_name	Chronic Myeloid Leukemia Treatments
topics[1].id	https://openalex.org/T12528
topics[1].field.id	https://openalex.org/fields/24
topics[1].field.display_name	Immunology and Microbiology
topics[1].score	0.9886999726295471
topics[1].domain.id	https://openalex.org/domains/1
topics[1].domain.display_name	Life Sciences
topics[1].subfield.id	https://openalex.org/subfields/2403
topics[1].subfield.display_name	Immunology
topics[1].display_name	IL-33, ST2, and ILC Pathways
topics[2].id	https://openalex.org/T12600
topics[2].field.id	https://openalex.org/fields/27
topics[2].field.display_name	Medicine
topics[2].score	0.9775000214576721
topics[2].domain.id	https://openalex.org/domains/4
topics[2].domain.display_name	Health Sciences
topics[2].subfield.id	https://openalex.org/subfields/2745
topics[2].subfield.display_name	Rheumatology
topics[2].display_name	Eosinophilic Disorders and Syndromes
is_xpac	False
apc_list
apc_paid
concepts[0].id	https://openalex.org/C2778729363
concepts[0].level	2
concepts[0].score	0.7576819658279419
concepts[0].wikidata	https://www.wikidata.org/wiki/Q11688946
concepts[0].display_name	Myeloid leukemia
concepts[1].id	https://openalex.org/C201750760
concepts[1].level	3
concepts[1].score	0.5466509461402893
concepts[1].wikidata	https://www.wikidata.org/wiki/Q1896218
concepts[1].display_name	Progenitor cell
concepts[2].id	https://openalex.org/C502942594
concepts[2].level	1
concepts[2].score	0.5445724725723267
concepts[2].wikidata	https://www.wikidata.org/wiki/Q3421914
concepts[2].display_name	Cancer research
concepts[3].id	https://openalex.org/C71924100
concepts[3].level	0
concepts[3].score	0.4972076714038849
concepts[3].wikidata	https://www.wikidata.org/wiki/Q11190
concepts[3].display_name	Medicine
concepts[4].id	https://openalex.org/C78780426
concepts[4].level	2
concepts[4].score	0.45598769187927246
concepts[4].wikidata	https://www.wikidata.org/wiki/Q902410
concepts[4].display_name	Deregulation
concepts[5].id	https://openalex.org/C10205521
concepts[5].level	3
concepts[5].score	0.4323316216468811
concepts[5].wikidata	https://www.wikidata.org/wiki/Q4035578
concepts[5].display_name	CD34
concepts[6].id	https://openalex.org/C109159458
concepts[6].level	3
concepts[6].score	0.41249802708625793
concepts[6].wikidata	https://www.wikidata.org/wiki/Q919283
concepts[6].display_name	Haematopoiesis
concepts[7].id	https://openalex.org/C203014093
concepts[7].level	1
concepts[7].score	0.32737255096435547
concepts[7].wikidata	https://www.wikidata.org/wiki/Q101929
concepts[7].display_name	Immunology
concepts[8].id	https://openalex.org/C86803240
concepts[8].level	0
concepts[8].score	0.24864482879638672
concepts[8].wikidata	https://www.wikidata.org/wiki/Q420
concepts[8].display_name	Biology
concepts[9].id	https://openalex.org/C95444343
concepts[9].level	1
concepts[9].score	0.1956849992275238
concepts[9].wikidata	https://www.wikidata.org/wiki/Q7141
concepts[9].display_name	Cell biology
concepts[10].id	https://openalex.org/C28328180
concepts[10].level	2
concepts[10].score	0.1698899269104004
concepts[10].wikidata	https://www.wikidata.org/wiki/Q48196
concepts[10].display_name	Stem cell
concepts[11].id	https://openalex.org/C162324750
concepts[11].level	0
concepts[11].score	0.07020303606987
concepts[11].wikidata	https://www.wikidata.org/wiki/Q8134
concepts[11].display_name	Economics
concepts[12].id	https://openalex.org/C139719470
concepts[12].level	1
concepts[12].score	0.0
concepts[12].wikidata	https://www.wikidata.org/wiki/Q39680
concepts[12].display_name	Macroeconomics
keywords[0].id	https://openalex.org/keywords/myeloid-leukemia
keywords[0].score	0.7576819658279419
keywords[0].display_name	Myeloid leukemia
keywords[1].id	https://openalex.org/keywords/progenitor-cell
keywords[1].score	0.5466509461402893
keywords[1].display_name	Progenitor cell
keywords[2].id	https://openalex.org/keywords/cancer-research
keywords[2].score	0.5445724725723267
keywords[2].display_name	Cancer research
keywords[3].id	https://openalex.org/keywords/medicine
keywords[3].score	0.4972076714038849
keywords[3].display_name	Medicine
keywords[4].id	https://openalex.org/keywords/deregulation
keywords[4].score	0.45598769187927246
keywords[4].display_name	Deregulation
keywords[5].id	https://openalex.org/keywords/cd34
keywords[5].score	0.4323316216468811
keywords[5].display_name	CD34
keywords[6].id	https://openalex.org/keywords/haematopoiesis
keywords[6].score	0.41249802708625793
keywords[6].display_name	Haematopoiesis
keywords[7].id	https://openalex.org/keywords/immunology
keywords[7].score	0.32737255096435547
keywords[7].display_name	Immunology
keywords[8].id	https://openalex.org/keywords/biology
keywords[8].score	0.24864482879638672
keywords[8].display_name	Biology
keywords[9].id	https://openalex.org/keywords/cell-biology
keywords[9].score	0.1956849992275238
keywords[9].display_name	Cell biology
keywords[10].id	https://openalex.org/keywords/stem-cell
keywords[10].score	0.1698899269104004
keywords[10].display_name	Stem cell
keywords[11].id	https://openalex.org/keywords/economics
keywords[11].score	0.07020303606987
keywords[11].display_name	Economics
language	en
locations[0].id	doi:10.1158/0008-5472.22398365.v1
locations[0].is_oa	True
locations[0].source
locations[0].license	cc-by
locations[0].pdf_url
locations[0].version	acceptedVersion
locations[0].raw_type	posted-content
locations[0].license_id	https://openalex.org/licenses/cc-by
locations[0].is_accepted	True
locations[0].is_published	False
locations[0].raw_source_name
locations[0].landing_page_url	https://doi.org/10.1158/0008-5472.22398365.v1
locations[1].id	pmh:oai:figshare.com:article/22398365
locations[1].is_oa	True
locations[1].source.id	https://openalex.org/S4306400572
locations[1].source.issn
locations[1].source.type	repository
locations[1].source.is_oa	False
locations[1].source.issn_l
locations[1].source.is_core	False
locations[1].source.is_in_doaj	False
locations[1].source.display_name	OPAL (Open@LaTrobe) (La Trobe University)
locations[1].source.host_organization	https://openalex.org/I196829312
locations[1].source.host_organization_name	La Trobe University
locations[1].source.host_organization_lineage	https://openalex.org/I196829312
locations[1].license	cc-by
locations[1].pdf_url
locations[1].version	submittedVersion
locations[1].raw_type	Text
locations[1].license_id	https://openalex.org/licenses/cc-by
locations[1].is_accepted	False
locations[1].is_published	False
locations[1].raw_source_name
locations[1].landing_page_url	https://figshare.com/articles/journal_contribution/Supplementary_Figure_5_from_BCR-ABL_Induced_Deregulation_of_the_IL-33_ST2_Pathway_in_CD34_Progenitors_from_Chronic_Myeloid_Leukemia_Patients/22398365
indexed_in	crossref
authorships[0].author.id	https://openalex.org/A5060249559
authorships[0].author.orcid	https://orcid.org/0000-0002-3892-9347
authorships[0].author.display_name	Anaïs Levescot
authorships[0].author_position	first
authorships[0].raw_author_name	Anaïs Levescot
authorships[0].is_corresponding	False
authorships[1].author.id	https://openalex.org/A5017658037
authorships[1].author.orcid	https://orcid.org/0000-0003-2295-5943
authorships[1].author.display_name	Stéphane Flamant
authorships[1].author_position	middle
authorships[1].raw_author_name	Stéphane Flamant
authorships[1].is_corresponding	False
authorships[2].author.id	https://openalex.org/A5058912031
authorships[2].author.orcid	https://orcid.org/0009-0005-9717-6399
authorships[2].author.display_name	Sara Basbous
authorships[2].author_position	middle
authorships[2].raw_author_name	Sara Basbous
authorships[2].is_corresponding	False
authorships[3].author.id	https://openalex.org/A5048299955
authorships[3].author.orcid	https://orcid.org/0000-0002-2851-2361
authorships[3].author.display_name	Florence Jacomet
authorships[3].author_position	middle
authorships[3].raw_author_name	Florence Jacomet
authorships[3].is_corresponding	False
authorships[4].author.id	https://openalex.org/A5011900089
authorships[4].author.orcid	https://orcid.org/0000-0002-5332-600X
authorships[4].author.display_name	Olivier Féraud
authorships[4].author_position	middle
authorships[4].raw_author_name	Olivier Féraud
authorships[4].is_corresponding	False
authorships[5].author.id	https://openalex.org/A5032149647
authorships[5].author.orcid
authorships[5].author.display_name	Elvire Anne Bourgeois
authorships[5].author_position	middle
authorships[5].raw_author_name	Elvire Anne Bourgeois
authorships[5].is_corresponding	False
authorships[6].author.id	https://openalex.org/A5103814735
authorships[6].author.orcid
authorships[6].author.display_name	Marie‐Laure Bonnet
authorships[6].author_position	middle
authorships[6].raw_author_name	Marie-Laure Bonnet
authorships[6].is_corresponding	False
authorships[7].author.id	https://openalex.org/A5088451153
authorships[7].author.orcid
authorships[7].author.display_name	Christine Giraud
authorships[7].author_position	middle
authorships[7].raw_author_name	Christine Giraud
authorships[7].is_corresponding	False
authorships[8].author.id	https://openalex.org/A5007454329
authorships[8].author.orcid	https://orcid.org/0000-0002-1833-9673
authorships[8].author.display_name	Lydia Roy
authorships[8].author_position	middle
authorships[8].raw_author_name	Lydia Roy
authorships[8].is_corresponding	False
authorships[9].author.id	https://openalex.org/A5110966451
authorships[9].author.orcid
authorships[9].author.display_name	Anne Barra
authorships[9].author_position	middle
authorships[9].raw_author_name	Anne Barra
authorships[9].is_corresponding	False
authorships[10].author.id	https://openalex.org/A5006400001
authorships[10].author.orcid	https://orcid.org/0000-0001-9227-1104
authorships[10].author.display_name	Jean‐Claude Chomel
authorships[10].author_position	middle
authorships[10].raw_author_name	Jean-Claude Chomel
authorships[10].is_corresponding	False
authorships[11].author.id	https://openalex.org/A5041347850
authorships[11].author.orcid	https://orcid.org/0000-0002-4861-0137
authorships[11].author.display_name	Ali G. Turhan
authorships[11].author_position	middle
authorships[11].raw_author_name	Ali Turhan
authorships[11].is_corresponding	False
authorships[12].author.id	https://openalex.org/A5079181777
authorships[12].author.orcid	https://orcid.org/0000-0001-7222-487X
authorships[12].author.display_name	François Guilhot
authorships[12].author_position	middle
authorships[12].raw_author_name	François Guilhot
authorships[12].is_corresponding	False
authorships[13].author.id	https://openalex.org/A5064398262
authorships[13].author.orcid	https://orcid.org/0000-0002-9154-1691
authorships[13].author.display_name	Jean‐Philippe Girard
authorships[13].author_position	middle
authorships[13].raw_author_name	Jean-Philippe Girard
authorships[13].is_corresponding	False
authorships[14].author.id	https://openalex.org/A5109985211
authorships[14].author.orcid
authorships[14].author.display_name	Jean‐Marc Gombert
authorships[14].author_position	middle
authorships[14].raw_author_name	Jean-Marc Gombert
authorships[14].is_corresponding	False
authorships[15].author.id	https://openalex.org/A5049544266
authorships[15].author.orcid	https://orcid.org/0000-0003-0193-7084
authorships[15].author.display_name	André Herbelin
authorships[15].author_position	last
authorships[15].raw_author_name	André Herbelin
authorships[15].is_corresponding	False
has_content.pdf	False
has_content.grobid_xml	False
is_paratext	False
open_access.is_oa	True
open_access.oa_url	https://doi.org/10.1158/0008-5472.22398365.v1
open_access.oa_status	gold
open_access.any_repository_has_fulltext	False
created_date	2025-10-10T00:00:00
display_name	Supplementary Figure 5 from BCR-ABL–Induced Deregulation of the IL-33/ST2 Pathway in CD34(+) Progenitors from Chronic Myeloid Leukemia Patients
has_fulltext	False
is_retracted	False
updated_date	2025-11-06T03:46:38.306776
primary_topic.id	https://openalex.org/T11215
primary_topic.field.id	https://openalex.org/fields/27
primary_topic.field.display_name	Medicine
primary_topic.score	0.9972000122070312
primary_topic.domain.id	https://openalex.org/domains/4
primary_topic.domain.display_name	Health Sciences
primary_topic.subfield.id	https://openalex.org/subfields/2720
primary_topic.subfield.display_name	Hematology
primary_topic.display_name	Chronic Myeloid Leukemia Treatments
related_works	https://openalex.org/W2146494723, https://openalex.org/W2140373631, https://openalex.org/W2212663083, https://openalex.org/W4309900040, https://openalex.org/W2091458058, https://openalex.org/W1888029756, https://openalex.org/W2006902667, https://openalex.org/W2981261950, https://openalex.org/W1998228373, https://openalex.org/W4362404260
cited_by_count	0
locations_count	2
best_oa_location.id	doi:10.1158/0008-5472.22398365.v1
best_oa_location.is_oa	True
best_oa_location.source
best_oa_location.license	cc-by
best_oa_location.pdf_url
best_oa_location.version	acceptedVersion
best_oa_location.raw_type	posted-content
best_oa_location.license_id	https://openalex.org/licenses/cc-by
best_oa_location.is_accepted	True
best_oa_location.is_published	False
best_oa_location.raw_source_name
best_oa_location.landing_page_url	https://doi.org/10.1158/0008-5472.22398365.v1
primary_location.id	doi:10.1158/0008-5472.22398365.v1
primary_location.is_oa	True
primary_location.source
primary_location.license	cc-by
primary_location.pdf_url
primary_location.version	acceptedVersion
primary_location.raw_type	posted-content
primary_location.license_id	https://openalex.org/licenses/cc-by
primary_location.is_accepted	True
primary_location.is_published	False
primary_location.raw_source_name
primary_location.landing_page_url	https://doi.org/10.1158/0008-5472.22398365.v1
publication_date	2023-03-30
publication_year	2023
referenced_works_count	0
abstract_inverted_index.-	2
abstract_inverted_index.in	8
abstract_inverted_index.to	10
abstract_inverted_index.file	1
abstract_inverted_index.from	13
abstract_inverted_index.IL-33	11
abstract_inverted_index.cells	6
abstract_inverted_index.154KB,	3
abstract_inverted_index.CML-CP	4
abstract_inverted_index.CD34(+)	5
abstract_inverted_index.response	9
abstract_inverted_index.proliferate	7
abstract_inverted_index.<p>PDF	0
abstract_inverted_index.independently	12
abstract_inverted_index.GM-CSF.</p>	14
cited_by_percentile_year
countries_distinct_count	0
institutions_distinct_count	16
citation_normalized_percentile.value	0.05157875
citation_normalized_percentile.is_in_top_1_percent	False
citation_normalized_percentile.is_in_top_10_percent	False